Robotic-assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
BJUI COMPASS, v.5, n.3, p.327-333, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction Surgical intervention is the treatment of choice in patients with urachal carcinoma. Due to complications and to reduce hospital stay from open surgery, minimally invasive approaches are desirable. Nowadays, robotic-assisted surgery has become increasingly popular, and robot-assisted cystectomy can be performed in patients with urachal carcinoma with low complication rates. Methods We performed a systematic review to search for studies that evaluated patients who underwent robotic-assisted surgery for urachal carcinoma. The outcomes of interest were the type of cystectomy performed, whether there was umbilicus resection, total operative time, console time, intraoperative complications, estimated blood loss, postoperative complications, time of hospitalisation, positive surgical margins and the presence of documented tumour recurrence. Results In this study, we evaluated three cohorts comprising a total of 21 patients. The median follow-up period ranged from 8 to 40 months. Medium age was between 51 and 54 years, with a majority (63.1%) being male. One patient (5.2%) underwent a radical cystectomy, and 19 patients (94.7%) underwent to partial cystectomy. Umbilical resections were performed in all cases, and pelvic lymphadenectomy in 14 cases (73.6%). Recurrence occurred in three patients at a median of 17 months postoperation, two cases in the trocar insertion site. Additionally, there was one death, which was attributed to postoperative cardiovascular complications. Conclusion Robotic-assisted partial cystectomy has a low incidence of adverse outcomes in patients with urachal carcinoma. Controlled studies, ideally randomised, are warranted to establish the comparative efficacy and safety of the robotic-assisted cystectomy approach relative to open surgery.
Palavras-chave
bladder cancer, partial cystectomy, robotic surgery, urachal adenocarcinoma, urachal carcinoma
URI
https://observatorio.fm.usp.br/handle/OPI/58835
Referências
  1. Allaparthi S, 2010, J ENDOUROL, V24, P223, DOI 10.1089/end.2009.0367
  2. [Anonymous], 2023, SCAND J UROL, V58, P1, DOI 10.2340/sju.v58.18375
  3. Ashley RA., 2003, UROLOGY, V61, P509
  4. Bogaerts Q., 2023, UROL VIDEO J, V17
  5. Bruins HM, 2012, J UROLOGY, V188, P1102, DOI 10.1016/j.juro.2012.06.020
  6. James Katherine, 2015, Curr Urol, V8, P183, DOI 10.1159/000365714
  7. Madeb R, 2006, BJU INT, V98, P838, DOI 10.1111/j.1464-410X.2006.06430.x
  8. Mantica G, 2020, J ROBOT SURG, V14, P805, DOI 10.1007/s11701-020-01062-x
  9. Moher D, 2015, SYST REV-LONDON, V4, DOI [10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2700, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535, 10.1136/bmj.i4086]
  10. Munn Z, 2020, JBI EVID SYNTH, V18, P2127, DOI 10.11124/JBISRIR-D-19-00099
  11. Peak TC, 2020, TRANSL ANDROL UROL, V9, P2938, DOI 10.21037/tau.2020.03.04
  12. Raymond SL, 2023, J ROBOT SURG, V17, P2427, DOI 10.1007/s11701-023-01667-y
  13. Schaefer IM, 2012, BJU INT, V109, P640, DOI 10.1111/j.1464-410X.2011.10916.x
  14. Song SH, 2023, CANCER RES TREAT, V55, P1337, DOI 10.4143/crt.2023.417
  15. Spiess PE, 2009, INT BRAZ J UROL, V35, P651, DOI 10.1590/S1677-55382009000500014
  16. Stokkel LE, 2022, UROL INT, V106, P840, DOI 10.1159/000521605
  17. Taktak S, 2023, CURR UROL, V17, P188, DOI 10.1097/CU9.0000000000000189
  18. Van Breusegem P, 2023, INDIA J SURG ONCOL, V14, P109, DOI 10.1007/s13193-022-01679-4
  19. Yu YD, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.683190

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCP